About this episode

This episode discusses the critical role of cybersecurity in the pharmaceutical and MedTech industries, emphasizing its impact on patient safety and regulatory compliance.

How can pharmaceutical and MedTech companies protect their products, data, systems, and patients in an environment where cyber threats are becoming more frequent, more sophisticated, and more operationally disruptive? Cybersecurity is no longer just an IT concern. In the pharmaceutical and medical technology industries, it has become a strategic and regulatory priority that directly affects product integrity, business continuity, patient safety, data protection, and market trust. In highly interconnected environments shaped by digital health platforms, connected medical devices, cloud-based quality systems, manufacturing automation, and global third-party networks, weaknesses in cybersecurity can result in data breaches, production interruptions, regulatory exposure, product vulnerabilities, financial loss, and lasting reputational harm. In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, provides an in-depth analysis of the growing role of cybersecurity across the pharmaceutical and MedTech sectors. The discussion explores how cybersecurity is no longer limited to technical infrastructure, but must be embedded into…

People in this episode

Guest: Dr. Diogo Sousa-Martins

Topics covered

• cybersecurity
• pharmaceutical industry
• MedTech
• data protection
• patient safety
• regulatory compliance

Keywords

• cyber threats
• data breaches
• product integrity
• business continuity
• digital health
• connected devices
• risk management

Mentioned in this episode

Organizations: ELS Group, International Pharma Talks

Explore listener stats, chart rankings, contacts and more on the International Pharma Talks podcast page.